Vergoeding 2016-2020 voor ATC-subgroep J05AF : Nucleoside en nucleotide reverse-transcriptaseremmers
- Raming voor de totale Zvw-populatie
| 2016 | 2017 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|---|
| J05AF01 Zidovudine (Retrovir ®) | 46.755 | 43.575 | 32.785 | 19.823 | 13.410 |
| J05AF02 Didanosine | 72.288 | 38.300 | 648 | . | . |
| J05AF04 Stavudine | 4.863 | 905 | . | . | . |
| J05AF05 Lamivudine (Epivir ®) | 723.910 | 592.810 | 529.170 | 424.540 | 297.600 |
| J05AF06 Abacavir (Ziagen ®) | 653.630 | 585.840 | 505.680 | 385.170 | 299.950 |
| J05AF07 Tenofovirdisoproxil (Viread ®) | 6.949.800 | 6.491.200 | 2.534.500 | 991.520 | 851.660 |
| J05AF08 Adefovir (Hepsera ®) | 431.190 | 377.140 | 340.800 | 245.680 | 187.960 |
| J05AF09 Emtricitabine (Emtriva ®) | 111.560 | 79.988 | 57.383 | 50.456 | 53.165 |
| J05AF10 Entecavir (Baraclude ®) | 7.099.800 | 7.478.300 | 3.425.200 | 1.483.900 | 1.614.400 |
| J05AF11 Telbivudine (Sebivo ®) | 21.624 | 22.045 | 24.060 | 19.588 | 1.860 |
| J05AF13 Tenofoviralafenamide (Vemlidy ®) | . | 58.306 | 519.990 | 1.102.600 | 1.570.500 |
| Totaal | 16.115.420 | 15.768.409 | 7.970.216 | 4.723.277 | 4.890.505 |